AstraZeneca PLC
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ZEG.F | MRK | PFE | NVS | LLY | BIIB | |
|---|---|---|---|---|---|---|
| Market cap | 259.78B | 370.96B | 175.50B | 311.59B | 1.26T | 37.61B |
| P/E (TTM) | 27.5 | 151.9 | 44.0 | 31.5 | 46.0 | 110.2 |
| Forward P/E | — | 16.7 | 10.6 | 16.6 | 28.3 | 15.6 |
| Price/book | 5.6 | 8.9 | 2.1 | 8.4 | 31.4 | 2.0 |
| Dividend yield | 1.68% | 2.26% | 5.59% | 2.87% | 0.49% | — |
| 1-year change | +16.72% | +75.29% | +23.90% | +30.35% | +51.26% | +62.35% |
| Today | −0.86% | +3.93% | +2.63% | +3.59% | +0.61% | +2.22% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All ZEG.F news ›AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
By Sabrina Valle, Milana Vinn and Amy-Jo Crowley Nov 4 (Reuters) - AstraZeneca made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people familiar with the matter. AstraZeneca offered…
More from 1 other outlet
AstraZeneca Filing Accepted in Europe and Japan for Lung Cancer
AstraZeneca’s regulatory filings for a TAGRISSO and ORPATHYS combination have been accepted in Europe and Japan for a form of non-small cell lung cancer. The… AstraZeneca (LSE:AZN) said its filings for the TAGRISSO plus ORPATHYS regimen…
AstraZeneca appoints Naveen Krishna Yamarthi as Managing Director, AstraZeneca India Private Limited (AZIPL) and Head of Global Innovation & Technology Centre, Chennai
Chennai, 04 November 2026: AstraZeneca announced the appointment of Naveen Krishna Yamarthi as Managing Director AZIPL and Head of its Global Innovation & Technology Centre (GITC), Chennai, effective 30 October 2026. In this role, Naveen…
AstraZeneca drops EU bid for Truqap in hormone-sensitive PTEN-deficient prostate cancer
AllSci AstraZeneca has withdrawn its application with the European Medicines Agency (EMA) to extend capivasertib (Truqap) to newly diagnosed metastatic PTEN-deficient hormone-sensitive prostate cancer after the C
OncoC4 Appoints Former AstraZeneca Executive Dan Janiak As Chief Business Officer
OncoC4, a clinical-stage biotechnology company developing cancer and immunology treatments, has appointed Dan Janiak, Ph.D., as Chief Business Officer. Janiak brings more than 15 years of experience in biotechnology financing, corporate…
RYTM Stock Clocks Best Day In Nearly 16 Months On AstraZeneca $10B Bid Report
Shares of Rhythm Pharmaceuticals (RYTM) closed up 28% on Wednesday, clocking its best day since July 2025, following reports that U.K-based pharma giant AstraZeneca had submitted a roughly $10 billion takeover proposal for it. According to…
Why Did AstraZeneca (LSE:AZN) Stock Jump After Its Cost-Savings Reset This Week?
Ecora Royalties (LSE:ECOR) Gets Cobalt Boost Below FTSE 100 Vanquis (LSE:VANQ) Rebuilds Returns Below the FTSE 100 Big Technologies (LSE:BIG) Braces for a Legal Fight Raspberry Pi (LSE:RPI) Founder Buys In Below the FTSE 100 The…
AstraZeneca Submits $10 Billion Takeover Offer for Rhythm Pharmaceuticals
AstraZeneca offered $124 per share to take over biotechnology company Rhythm Pharmaceuticals, The Wall Street Journal reported Wednesday, citing people familiar with the matter. The unnamed... AstraZeneca Submits $10 Billion Takeover Offer…
AstraZeneca PLC : DZ Bank keeps its Buy rating
DZ Bank is positive on the stock with a Buy rating. AstraZeneca PLC : DZ Bank keeps its Buy rating Published on 11/03/2026 at 12:24 pm EST Latest news about AstraZeneca PLC Income Statement and Estimates AstraZeneca Retains Shareholder…
Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma, BeiGene, Zymeworks, ALX Oncology
Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing openPR.com Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com87
- seekingalpha.com10
- tradingview.com9
- statnews.com8
- defenseworld.net7
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.